IBDEI0DD ; ; 01-MAY-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 01, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,660,0)
 ;;=STATUS POST & HX OF^26^57
 ;;^UTILITY(U,$J,358.4,661,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^28^57
 ;;^UTILITY(U,$J,358.4,662,0)
 ;;=NEW PATIENT^2^58
 ;;^UTILITY(U,$J,358.4,663,0)
 ;;=ESTABLISHED PATIENT^1^58
 ;;^UTILITY(U,$J,358.4,664,0)
 ;;=CONSULTATIONS^3^58
 ;;^UTILITY(U,$J,358.4,665,0)
 ;;=IMMUNIZATIONS^3^59
 ;;^UTILITY(U,$J,358.4,666,0)
 ;;=COUNSELING/EDUCATION^1^59
 ;;^UTILITY(U,$J,358.4,667,0)
 ;;=PROLONGED SERVICES^5^59
 ;;^UTILITY(U,$J,358.4,668,0)
 ;;=IMMUNIZATION ADMIN^2^59
 ;;^UTILITY(U,$J,358.4,669,0)
 ;;=WOUND CARE^7^59
 ;;^UTILITY(U,$J,358.4,670,0)
 ;;=SKIN TEST^6^59
 ;;^UTILITY(U,$J,358.4,671,0)
 ;;=MEDICATION ADMIN^4^59
 ;;^UTILITY(U,$J,358.4,672,0)
 ;;=ID-GENERAL^1^60
 ;;^UTILITY(U,$J,358.4,673,0)
 ;;=ID-HIV^2^60
 ;;^UTILITY(U,$J,358.4,674,0)
 ;;=POSTPROCEDURAL INFECTIONS^4^60
 ;;^UTILITY(U,$J,358.4,675,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^5^60
 ;;^UTILITY(U,$J,358.4,676,0)
 ;;=COVID-19^3^60
 ;;^UTILITY(U,$J,358.4,677,0)
 ;;=MFH-NON CLINICIAN VISIT ^2^61
 ;;^UTILITY(U,$J,358.4,678,0)
 ;;=NURSING PROCEDURES^3^61
 ;;^UTILITY(U,$J,358.4,679,0)
 ;;=SPLINTS^4^61
 ;;^UTILITY(U,$J,358.4,680,0)
 ;;=MFH-CLINICIAN VISIT ^1^61
 ;;^UTILITY(U,$J,358.4,681,0)
 ;;=VACCINE ADMINISTRATION^5^61
 ;;^UTILITY(U,$J,358.4,682,0)
 ;;=VACCINES^6^61
 ;;^UTILITY(U,$J,358.4,683,0)
 ;;=PC COMMON DIAGNOSES^1^62
 ;;^UTILITY(U,$J,358.4,684,0)
 ;;=ADMINISTRATIVE TOPICS^15^62
 ;;^UTILITY(U,$J,358.4,685,0)
 ;;=ANGINA^16^62
 ;;^UTILITY(U,$J,358.4,686,0)
 ;;=ATHEROSCLEROSIS^17^62
 ;;^UTILITY(U,$J,358.4,687,0)
 ;;=CARDIOVASCULAR^18^62
 ;;^UTILITY(U,$J,358.4,688,0)
 ;;=DERMATOLOGY^22^62
 ;;^UTILITY(U,$J,358.4,689,0)
 ;;=EAR DISORDERS^24^62
 ;;^UTILITY(U,$J,358.4,690,0)
 ;;=EENT^25^62
 ;;^UTILITY(U,$J,358.4,691,0)
 ;;=ENDOCRINE/METABOLIC^26^62
 ;;^UTILITY(U,$J,358.4,692,0)
 ;;=EYE DISORDERS^27^62
 ;;^UTILITY(U,$J,358.4,693,0)
 ;;=EYE INJURY^28^62
 ;;^UTILITY(U,$J,358.4,694,0)
 ;;=GASTROENTEROLOGY^29^62
 ;;^UTILITY(U,$J,358.4,695,0)
 ;;=GU/RENAL^30^62
 ;;^UTILITY(U,$J,358.4,696,0)
 ;;=HEADACHE^31^62
 ;;^UTILITY(U,$J,358.4,697,0)
 ;;=HEART VALVE DISEASE^32^62
 ;;^UTILITY(U,$J,358.4,698,0)
 ;;=HEMATOLOGY/ONCOLOGY^33^62
 ;;^UTILITY(U,$J,358.4,699,0)
 ;;=HISTORY OF ILLNESS^34^62
 ;;^UTILITY(U,$J,358.4,700,0)
 ;;=INFECTIOUS DISEASE^35^62
 ;;^UTILITY(U,$J,358.4,701,0)
 ;;=LIVER DISEASE^36^62
 ;;^UTILITY(U,$J,358.4,702,0)
 ;;=MENTAL HEALTH^38^62
 ;;^UTILITY(U,$J,358.4,703,0)
 ;;=MOVEMENT DISORDERS^39^62
 ;;^UTILITY(U,$J,358.4,704,0)
 ;;=MUSCULOSKELETAL^40^62
 ;;^UTILITY(U,$J,358.4,705,0)
 ;;=NEUROLOGY^41^62
 ;;^UTILITY(U,$J,358.4,706,0)
 ;;=PAIN^42^62
 ;;^UTILITY(U,$J,358.4,707,0)
 ;;=PREVENTIVE HEALTH^43^62
 ;;^UTILITY(U,$J,358.4,708,0)
 ;;=PULMONARY^44^62
 ;;^UTILITY(U,$J,358.4,709,0)
 ;;=SEXUAL TRAUMA^45^62
 ;;^UTILITY(U,$J,358.4,710,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^46^62
 ;;^UTILITY(U,$J,358.4,711,0)
 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^62
 ;;^UTILITY(U,$J,358.4,712,0)
 ;;=SUBSTANCE DISORDERS^48^62
 ;;^UTILITY(U,$J,358.4,713,0)
 ;;=VARICOSE VEINS^50^62
 ;;^UTILITY(U,$J,358.4,714,0)
 ;;=WOMEN'S HEALTH^51^62
 ;;^UTILITY(U,$J,358.4,715,0)
 ;;=WOUNDS-INITIAL ENCOUNTER^52^62
 ;;^UTILITY(U,$J,358.4,716,0)
 ;;=COMA^20^62
 ;;^UTILITY(U,$J,358.4,717,0)
 ;;=CAUSES OF INJURY^19^62
 ;;^UTILITY(U,$J,358.4,718,0)
 ;;=DEMENTIA^21^62
 ;;^UTILITY(U,$J,358.4,719,0)
 ;;=LONG TERM CURRENT DRUG THERAPY^37^62
 ;;^UTILITY(U,$J,358.4,720,0)
 ;;=ACQUIRED ABSENCE OF BODY PART(S)^2^62
 ;;^UTILITY(U,$J,358.4,721,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^49^62
 ;;^UTILITY(U,$J,358.4,722,0)
 ;;=ACSC ACUTE KIDNEY FAILURE^3^62
 ;;^UTILITY(U,$J,358.4,723,0)
 ;;=ACSC ANGINA^4^62
 ;;^UTILITY(U,$J,358.4,724,0)
 ;;=ACSC ASTHMA/BRONCHITIS/COPD^5^62
 ;;^UTILITY(U,$J,358.4,725,0)
 ;;=ACSC CHF^6^62
 ;;^UTILITY(U,$J,358.4,726,0)
 ;;=ACSC DEHYDRATION^7^62
 ;;^UTILITY(U,$J,358.4,727,0)
 ;;=ACSC DIABETES TYPE 1^8^62
 ;;^UTILITY(U,$J,358.4,728,0)
 ;;=ACSC DIABETES TYPE 2^9^62
 ;;^UTILITY(U,$J,358.4,729,0)
 ;;=ACSC HYPERTENSION^10^62
 ;;^UTILITY(U,$J,358.4,730,0)
 ;;=ACSC INFECTIOUS GASTROENTERITIS^11^62
 ;;^UTILITY(U,$J,358.4,731,0)
 ;;=ACSC PNEUMONIA^12^62
 ;;^UTILITY(U,$J,358.4,732,0)
 ;;=ACSC UTI^13^62
 ;;^UTILITY(U,$J,358.4,733,0)
 ;;=ACSC VIRAL ENTERITIS^14^62
 ;;^UTILITY(U,$J,358.4,734,0)
 ;;=E-CIG/VAPE LUNG INJURY^23^62
 ;;^UTILITY(U,$J,358.4,735,0)
 ;;=NEW PATIENT^2^63
 ;;^UTILITY(U,$J,358.4,736,0)
 ;;=ESTABLISHED PATIENT^1^63
 ;;^UTILITY(U,$J,358.4,737,0)
 ;;=CONSULTATIONS^3^63
 ;;^UTILITY(U,$J,358.4,738,0)
 ;;=PREVENTIVE MED-EST PT^4^63
 ;;^UTILITY(U,$J,358.4,739,0)
 ;;=PREVENTIVE MED-NEW PT^5^63
 ;;^UTILITY(U,$J,358.4,740,0)
 ;;=IMMUNIZATIONS^5^64
 ;;^UTILITY(U,$J,358.4,741,0)
 ;;=INJECTION^6^64
 ;;^UTILITY(U,$J,358.4,742,0)
 ;;=SKIN TESTS^13^64
 ;;^UTILITY(U,$J,358.4,743,0)
 ;;=NURSING PROCEDURES^8^64
 ;;^UTILITY(U,$J,358.4,744,0)
 ;;=MINOR PROCEDURES^7^64
 ;;^UTILITY(U,$J,358.4,745,0)
 ;;=SPLINTS^14^64
 ;;^UTILITY(U,$J,358.4,746,0)
 ;;=REPAIR-SIMPLE SCALP,NK,TRUNK,GENTIALS^12^64
 ;;^UTILITY(U,$J,358.4,747,0)
 ;;=REPAIR-SIMPLE FACE,MUCOUS^11^64
 ;;^UTILITY(U,$J,358.4,748,0)
 ;;=IMMUNIZATION ADMIN^4^64
 ;;^UTILITY(U,$J,358.4,749,0)
 ;;=BEHAVIOR CHANGE INTERVENTION^2^64
 ;;^UTILITY(U,$J,358.4,750,0)
 ;;=ADVANCE CARE PLANNING^1^64
 ;;^UTILITY(U,$J,358.4,751,0)
 ;;=PREVENTIVE MED-EST PT^9^64
 ;;^UTILITY(U,$J,358.4,752,0)
 ;;=PREVENTIVE MED-NEW PT^10^64
 ;;^UTILITY(U,$J,358.4,753,0)
 ;;=E-CONSULT REFERRAL^3^64
 ;;^UTILITY(U,$J,358.4,754,0)
 ;;=PC COMMON DIAGNOSES^1^65
 ;;^UTILITY(U,$J,358.4,755,0)
 ;;=ADMINISTRATIVE TOPICS^15^65
 ;;^UTILITY(U,$J,358.4,756,0)
 ;;=ANGINA^16^65
 ;;^UTILITY(U,$J,358.4,757,0)
 ;;=ATHEROSCLEROSIS^17^65
 ;;^UTILITY(U,$J,358.4,758,0)
 ;;=CARDIOVASCULAR^18^65
 ;;^UTILITY(U,$J,358.4,759,0)
 ;;=DERMATOLOGY^22^65
 ;;^UTILITY(U,$J,358.4,760,0)
 ;;=EAR DISORDERS^24^65
 ;;^UTILITY(U,$J,358.4,761,0)
 ;;=EENT^25^65
 ;;^UTILITY(U,$J,358.4,762,0)
 ;;=ENDOCRINE/METABOLIC^26^65
 ;;^UTILITY(U,$J,358.4,763,0)
 ;;=EYE DISORDERS^27^65
 ;;^UTILITY(U,$J,358.4,764,0)
 ;;=EYE INJURY^28^65
 ;;^UTILITY(U,$J,358.4,765,0)
 ;;=GASTROENTEROLOGY^29^65
 ;;^UTILITY(U,$J,358.4,766,0)
 ;;=GU/RENAL^30^65
 ;;^UTILITY(U,$J,358.4,767,0)
 ;;=HEADACHE^31^65
 ;;^UTILITY(U,$J,358.4,768,0)
 ;;=HEART VALVE DISEASE^32^65
 ;;^UTILITY(U,$J,358.4,769,0)
 ;;=HEMATOLOGY/ONCOLOGY^33^65
 ;;^UTILITY(U,$J,358.4,770,0)
 ;;=HISTORY OF ILLNESS^34^65
 ;;^UTILITY(U,$J,358.4,771,0)
 ;;=INFECTIOUS DISEASE^35^65
 ;;^UTILITY(U,$J,358.4,772,0)
 ;;=LIVER DISEASE^36^65
 ;;^UTILITY(U,$J,358.4,773,0)
 ;;=MENTAL HEALTH^38^65
 ;;^UTILITY(U,$J,358.4,774,0)
 ;;=MOVEMENT DISORDERS^39^65
 ;;^UTILITY(U,$J,358.4,775,0)
 ;;=MUSCULOSKELETAL^40^65
 ;;^UTILITY(U,$J,358.4,776,0)
 ;;=NEUROLOGY^41^65
 ;;^UTILITY(U,$J,358.4,777,0)
 ;;=PAIN^42^65
 ;;^UTILITY(U,$J,358.4,778,0)
 ;;=PREVENTIVE HEALTH^43^65
 ;;^UTILITY(U,$J,358.4,779,0)
 ;;=PULMONARY^44^65
 ;;^UTILITY(U,$J,358.4,780,0)
 ;;=SEXUAL TRAUMA^45^65
 ;;^UTILITY(U,$J,358.4,781,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^46^65
 ;;^UTILITY(U,$J,358.4,782,0)
 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^65
 ;;^UTILITY(U,$J,358.4,783,0)
 ;;=SUBSTANCE DISORDERS^48^65
 ;;^UTILITY(U,$J,358.4,784,0)
 ;;=VARICOSE VEINS^50^65
 ;;^UTILITY(U,$J,358.4,785,0)
 ;;=WOMEN'S HEALTH^51^65
 ;;^UTILITY(U,$J,358.4,786,0)
 ;;=WOUNDS-INITIAL ENCOUNTER^52^65
 ;;^UTILITY(U,$J,358.4,787,0)
 ;;=COMA^20^65
 ;;^UTILITY(U,$J,358.4,788,0)
 ;;=CAUSES OF INJURY^19^65
 ;;^UTILITY(U,$J,358.4,789,0)
 ;;=DEMENTIA^21^65
 ;;^UTILITY(U,$J,358.4,790,0)
 ;;=LONG TERM CURRENT DRUG THERAPY^37^65
 ;;^UTILITY(U,$J,358.4,791,0)
 ;;=ACQUIRED ABSENCE OF BODY PART(S)^2^65
 ;;^UTILITY(U,$J,358.4,792,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^49^65
 ;;^UTILITY(U,$J,358.4,793,0)
 ;;=ACSC ACUTE KIDNEY FAILURE^3^65
 ;;^UTILITY(U,$J,358.4,794,0)
 ;;=ACSC ANGINA^4^65
 ;;^UTILITY(U,$J,358.4,795,0)
 ;;=ACSC ASTHMA/BRONCHITIS/COPD^5^65
 ;;^UTILITY(U,$J,358.4,796,0)
 ;;=ACSC CHF^6^65
 ;;^UTILITY(U,$J,358.4,797,0)
 ;;=ACSC DEHYDRATION^7^65
 ;;^UTILITY(U,$J,358.4,798,0)
 ;;=ACSC DIABETES TYPE 1^8^65
 ;;^UTILITY(U,$J,358.4,799,0)
 ;;=ACSC DIABETES TYPE 2^9^65
 ;;^UTILITY(U,$J,358.4,800,0)
 ;;=ACSC HYPERTENSION^10^65
 ;;^UTILITY(U,$J,358.4,801,0)
 ;;=ACSC INFECTIOUS GASTROENTERITIS^11^65
 ;;^UTILITY(U,$J,358.4,802,0)
 ;;=ACSC PNEUMONIA^12^65
 ;;^UTILITY(U,$J,358.4,803,0)
 ;;=ACSC UTI^13^65
 ;;^UTILITY(U,$J,358.4,804,0)
 ;;=ACSC VIRAL ENTERITIS^14^65
 ;;^UTILITY(U,$J,358.4,805,0)
 ;;=E-CIG/VAPE LUNG INJURY^23^65
 ;;^UTILITY(U,$J,358.4,806,0)
 ;;=PSYCHOTHERAPY (INPT OR OUTPT)^7^66
 ;;^UTILITY(U,$J,358.4,807,0)
 ;;=PSYCHOTHERAPY FOR CRISIS^8^66
 ;;^UTILITY(U,$J,358.4,808,0)
 ;;=OTHER CODES^4^66
 ;;^UTILITY(U,$J,358.4,809,0)
 ;;=HEALTH/BEHAVIOR ASSESSMENT/INTERVENTION^1^66
 ;;^UTILITY(U,$J,358.4,810,0)
 ;;=TEAM CONFERENCE^10^66
 ;;^UTILITY(U,$J,358.4,811,0)
 ;;=INTERACTIVE COMPLEXITY ADD-ON^2^66
 ;;^UTILITY(U,$J,358.4,812,0)
 ;;=SUBSTANCE USE^9^66
 ;;^UTILITY(U,$J,358.4,813,0)
 ;;=PSYCHIATRIC DIAGNOSTIC EVALUATION^6^66
 ;;^UTILITY(U,$J,358.4,814,0)
 ;;=PROLONGED SERVICE^5^66
 ;;^UTILITY(U,$J,358.4,815,0)
 ;;=TOBACCO CESSATION COUNSELING^11^66
 ;;^UTILITY(U,$J,358.4,816,0)
 ;;=NEUROPSYCH TESTING^3^66
 ;;^UTILITY(U,$J,358.4,817,0)
 ;;=ABUSE,NEGLECT, & VIOLENCE^1^67
 ;;^UTILITY(U,$J,358.4,818,0)
 ;;=ANXIETY DISORDERS^2^67
 ;;^UTILITY(U,$J,358.4,819,0)
 ;;=BIPOLAR & RELATED DISORDERS^3^67
 ;;^UTILITY(U,$J,358.4,820,0)
 ;;=NEUROCOGNITIVE DISORDERS^17^67
 ;;^UTILITY(U,$J,358.4,821,0)
 ;;=DEPRESSIVE DISORDERS^7^67
 ;;^UTILITY(U,$J,358.4,822,0)
 ;;=DISSOCIATIVE DISORDERS ^9^67
 ;;^UTILITY(U,$J,358.4,823,0)
 ;;=FEEDING & EATING DISORDERS^12^67
 ;;^UTILITY(U,$J,358.4,824,0)
 ;;=EDUC/OCCUPATIONAL PROBLEMS^10^67
 ;;^UTILITY(U,$J,358.4,825,0)
 ;;=GENDER DYSPHORIA^14^67
 ;;^UTILITY(U,$J,358.4,826,0)
 ;;=HOUSING/ECONOMIC PROBLEMS^15^67
 ;;^UTILITY(U,$J,358.4,827,0)
 ;;=MEDICATION ADVERSE EFFECTS^16^67
 ;;^UTILITY(U,$J,358.4,828,0)
 ;;=OBSESSIVE-COMPULSIVE & RELATED DISORDERS^19^67
 ;;^UTILITY(U,$J,358.4,829,0)
 ;;=PERSONAL HX & CURRENT CIRCUMSTANCES^22^67
 ;;^UTILITY(U,$J,358.4,830,0)
 ;;=COUNSELING/MEDICAL ADVICE^5^67
 ;;^UTILITY(U,$J,358.4,831,0)
 ;;=SOCIAL ENVIRONMENT PROBLEMS^29^67
 ;;^UTILITY(U,$J,358.4,832,0)
 ;;=PARAPHILIC DISORDERS^21^67
 ;;^UTILITY(U,$J,358.4,833,0)
 ;;=PERSONALITY DISORDERS^23^67
 ;;^UTILITY(U,$J,358.4,834,0)
 ;;=CRIME/LEGAL SYSTEM PROBLEMS^6^67
 ;;^UTILITY(U,$J,358.4,835,0)
 ;;=PSYCHOSOCIAL/PERSONAL/ENVIRONMENTAL^24^67
 ;;^UTILITY(U,$J,358.4,836,0)
 ;;=RELATIONAL PROBLEMS^25^67
 ;;^UTILITY(U,$J,358.4,837,0)
 ;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^26^67
 ;;^UTILITY(U,$J,358.4,838,0)
 ;;=SEXUAL DYSFUNCTIONS^27^67
 ;;^UTILITY(U,$J,358.4,839,0)
 ;;=SLEEP-WAKE DISORDERS^28^67
 ;;^UTILITY(U,$J,358.4,840,0)
 ;;=SUBSTANCE DISORDER-ALCOHOL^31^67
 ;;^UTILITY(U,$J,358.4,841,0)
 ;;=SUBSTANCE DISORDER-CANNABIS^33^67
 ;;^UTILITY(U,$J,358.4,842,0)
 ;;=SUBSTANCE DISORDER-HALLUCINOGEN^34^67
 ;;^UTILITY(U,$J,358.4,843,0)
 ;;=SUBSTANCE DISORDER-OPIOID^36^67
 ;;^UTILITY(U,$J,358.4,844,0)
 ;;=SUBSTANCE DISORDER-SEDATIVE/HYPNOTIC^37^67
 ;;^UTILITY(U,$J,358.4,845,0)
 ;;=SUBSTANCE DISORDER-TOBACCO^39^67
 ;;^UTILITY(U,$J,358.4,846,0)
 ;;=TRAUMA/STRESSOR-RELATED DISORDERS^42^67
 ;;^UTILITY(U,$J,358.4,847,0)
 ;;=SUBSTANCE DISORDER-INHALANT^35^67
 ;;^UTILITY(U,$J,358.4,848,0)
 ;;=CLINICAL RESEARCH PROGRAM^4^67
 ;;^UTILITY(U,$J,358.4,849,0)
 ;;=SOMATIC SYMPTOM & RELATED DISORDERS^30^67
 ;;^UTILITY(U,$J,358.4,850,0)
 ;;=DISRUPTIVE,IMPULSE,CONDUCT D/O^8^67
 ;;^UTILITY(U,$J,358.4,851,0)
 ;;=ELIMINATION DISORDERS^11^67
 ;;^UTILITY(U,$J,358.4,852,0)
 ;;=GAMBLING DISORDER^13^67
 ;;^UTILITY(U,$J,358.4,853,0)
 ;;=OTHER MENTAL DISORDERS^20^67
 ;;^UTILITY(U,$J,358.4,854,0)
 ;;=NEURODEVELOPMENTAL DISORDERS^18^67
 ;;^UTILITY(U,$J,358.4,855,0)
 ;;=SUBSTANCE DISORDER-CAFFEINE^32^67
 ;;^UTILITY(U,$J,358.4,856,0)
 ;;=SUICIDAL IDEATIONS/ATTEMPTS^41^67
 ;;^UTILITY(U,$J,358.4,857,0)
 ;;=SUBSTANCE DISORDER-UNKNOWN SUBSTANCE^40^67
 ;;^UTILITY(U,$J,358.4,858,0)
 ;;=SUBSTANCE DISORDER-STIMULANTS^38^67
 ;;^UTILITY(U,$J,358.4,859,0)
 ;;=UNDERDOSING OF MEDICATION REGIMEN^43^67
 ;;^UTILITY(U,$J,358.4,860,0)
 ;;=ESTABLISHED PATIENT^2^68
 ;;^UTILITY(U,$J,358.4,861,0)
 ;;=INJECTIONS/MEDICATION^13^69
 ;;^UTILITY(U,$J,358.4,862,0)
 ;;=OTHER^14^69
 ;;^UTILITY(U,$J,358.4,863,0)
 ;;=ALLERGY INJECTION^1^69
 ;;^UTILITY(U,$J,358.4,864,0)
 ;;=INJECTION ADMINISTRATION^12^69
 ;;^UTILITY(U,$J,358.4,865,0)
 ;;=IMMUNIZATION ADMINISTRATION ^8^69
 ;;^UTILITY(U,$J,358.4,866,0)
 ;;=CATHETER^3^69
 ;;^UTILITY(U,$J,358.4,867,0)
 ;;=CATH FLUSHES^4^69
 ;;^UTILITY(U,$J,358.4,868,0)
 ;;=PFT^15^69
 ;;^UTILITY(U,$J,358.4,869,0)
 ;;=EKG/HOLTER MONITOR^7^69
 ;;^UTILITY(U,$J,358.4,870,0)
 ;;=IMMUNIZATIONS^9^69
 ;;^UTILITY(U,$J,358.4,871,0)
 ;;=INFUSIONS^11^69
 ;;^UTILITY(U,$J,358.4,872,0)
 ;;=PICC^16^69
 ;;^UTILITY(U,$J,358.4,873,0)
 ;;=CHEMO AND OTH COMPLEX DRUGS^5^69
 ;;^UTILITY(U,$J,358.4,874,0)
 ;;=BLOOD TRANSFUSIONS^2^69
 ;;^UTILITY(U,$J,358.4,875,0)
 ;;=EDUCATION^6^69
 ;;^UTILITY(U,$J,358.4,876,0)
 ;;=PRESSURE ULCER^14^70
 ;;^UTILITY(U,$J,358.4,877,0)
 ;;=SKIN^19^70
 ;;^UTILITY(U,$J,358.4,878,0)
 ;;=SIGNS AND SYMPTOMS^1^70
 ;;^UTILITY(U,$J,358.4,879,0)
 ;;=CARDIO/VASCULAR^2^70
 ;;^UTILITY(U,$J,358.4,880,0)
 ;;=COUNSELING^3^70
 ;;^UTILITY(U,$J,358.4,881,0)
 ;;=ENDOCRINE,METABOLIC,NUTRITION^4^70
 ;;^UTILITY(U,$J,358.4,882,0)
 ;;=ENT^5^70
 ;;^UTILITY(U,$J,358.4,883,0)
 ;;=GASTROINTESTINAL^6^70
 ;;^UTILITY(U,$J,358.4,884,0)
 ;;=GENITOURINARY & RENAL^7^70
 ;;^UTILITY(U,$J,358.4,885,0)
 ;;=HEPATITIS^8^70
 ;;^UTILITY(U,$J,358.4,886,0)
 ;;=IMMUNIZATIONS^9^70
 ;;^UTILITY(U,$J,358.4,887,0)
 ;;=MUSCULOSKELETAL^10^70
 ;;^UTILITY(U,$J,358.4,888,0)
 ;;=NEUROLOGY^11^70
 ;;^UTILITY(U,$J,358.4,889,0)
 ;;=NURSING MISCELLANEOUS^12^70
 ;;^UTILITY(U,$J,358.4,890,0)
 ;;=PREVENTIVE MEDICINE^15^70
 ;;^UTILITY(U,$J,358.4,891,0)
 ;;=PULMONARY/RESPIRATORY^16^70
 ;;^UTILITY(U,$J,358.4,892,0)
 ;;=PSYCHIATRIC^17^70
 ;;^UTILITY(U,$J,358.4,893,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^20^70
 ;;^UTILITY(U,$J,358.4,894,0)
 ;;=OSTOMY STATUS^13^70
 ;;^UTILITY(U,$J,358.4,895,0)
 ;;=SCREENING^18^70
 ;;^UTILITY(U,$J,358.4,896,0)
 ;;=NEW PATIENT^2^71
 ;;^UTILITY(U,$J,358.4,897,0)
 ;;=ESTABLISHED PATIENT^1^71
 ;;^UTILITY(U,$J,358.4,898,0)
 ;;=CONSULTATIONS^3^71
 ;;^UTILITY(U,$J,358.4,899,0)
 ;;=PREVENTIVE MED-EST PT^4^71
 ;;^UTILITY(U,$J,358.4,900,0)
 ;;=PREVENTIVE MED-NEW PT^5^71
 ;;^UTILITY(U,$J,358.4,901,0)
 ;;=INJECTION^11^72
 ;;^UTILITY(U,$J,358.4,902,0)
 ;;=SKIN TEST^23^72
 ;;^UTILITY(U,$J,358.4,903,0)
 ;;=NURSING PROCEDURES^13^72
 ;;^UTILITY(U,$J,358.4,904,0)
 ;;=MINOR PROCEDURES^12^72
 ;;^UTILITY(U,$J,358.4,905,0)
 ;;=SPLINTS^24^72
 ;;^UTILITY(U,$J,358.4,906,0)
 ;;=EDUCATION/TRAINING^5^72
 ;;^UTILITY(U,$J,358.4,907,0)
 ;;=ALLERGY SHOTS^2^72
 ;;^UTILITY(U,$J,358.4,908,0)
 ;;=EKG^6^72
 ;;^UTILITY(U,$J,358.4,909,0)
 ;;=BEHAVIORAL CHANGE INTERVENTION^3^72
 ;;^UTILITY(U,$J,358.4,910,0)
 ;;=OTH PREVENTIVE MEDICINE SVCS^14^72
 ;;^UTILITY(U,$J,358.4,911,0)
 ;;=GYN PROCEDURES^7^72
 ;;^UTILITY(U,$J,358.4,912,0)
 ;;=RISK FACTOR REDUCTION^22^72
 ;;^UTILITY(U,$J,358.4,913,0)
 ;;=PREVENTIVE GROUP COUNSELING^16^72
 ;;^UTILITY(U,$J,358.4,914,0)
 ;;=PROLONGED SERVICE^19^72
 ;;^UTILITY(U,$J,358.4,915,0)
 ;;=IMMUNIZATION ADMINISTRATION^9^72
 ;;^UTILITY(U,$J,358.4,916,0)
 ;;=REPAIR-SIMPLE FACE/MUCOUS^20^72
 ;;^UTILITY(U,$J,358.4,917,0)
 ;;=REPAIR-SIMPLE SCALP/NK/TRUNK^21^72
 ;;^UTILITY(U,$J,358.4,918,0)
 ;;=PREVENTIVE MED-EST PT^17^72
 ;;^UTILITY(U,$J,358.4,919,0)
 ;;=PREVENTIVE MED-NEW PT^18^72
 ;;^UTILITY(U,$J,358.4,920,0)
 ;;=ADVANCE CARE PLANNING^1^72
 ;;^UTILITY(U,$J,358.4,921,0)
 ;;=HEALTH BEHAVIORAL ASSESSMENT^8^72
 ;;^UTILITY(U,$J,358.4,922,0)
 ;;=PHARMACY SERVICES^15^72
 ;;^UTILITY(U,$J,358.4,923,0)
 ;;=IMMUNIZATIONS^10^72
 ;;^UTILITY(U,$J,358.4,924,0)
 ;;=E-CONSULT REFERRAL^4^72
 ;;^UTILITY(U,$J,358.4,925,0)
 ;;=PC COMMON DIAGNOSES^1^73
 ;;^UTILITY(U,$J,358.4,926,0)
 ;;=ADMINISTRATIVE TOPICS^15^73
 ;;^UTILITY(U,$J,358.4,927,0)
 ;;=ANGINA^16^73
 ;;^UTILITY(U,$J,358.4,928,0)
 ;;=ATHEROSCLEROSIS^17^73
 ;;^UTILITY(U,$J,358.4,929,0)
 ;;=CARDIOVASCULAR^18^73
 ;;^UTILITY(U,$J,358.4,930,0)
 ;;=DERMATOLOGY^22^73
 ;;^UTILITY(U,$J,358.4,931,0)
 ;;=EAR DISORDERS^24^73
 ;;^UTILITY(U,$J,358.4,932,0)
 ;;=EENT^25^73
 ;;^UTILITY(U,$J,358.4,933,0)
 ;;=ENDOCRINE/METABOLIC^26^73
 ;;^UTILITY(U,$J,358.4,934,0)
 ;;=EYE DISORDERS^27^73
 ;;^UTILITY(U,$J,358.4,935,0)
 ;;=EYE INJURY^28^73
 ;;^UTILITY(U,$J,358.4,936,0)
 ;;=GASTROENTEROLOGY^29^73
 ;;^UTILITY(U,$J,358.4,937,0)
 ;;=GU/RENAL^30^73
 ;;^UTILITY(U,$J,358.4,938,0)
 ;;=HEADACHE^31^73
 ;;^UTILITY(U,$J,358.4,939,0)
 ;;=HEART VALVE DISEASE^32^73
 ;;^UTILITY(U,$J,358.4,940,0)
 ;;=HEMATOLOGY/ONCOLOGY^33^73
 ;;^UTILITY(U,$J,358.4,941,0)
 ;;=HISTORY OF ILLNESS^34^73
 ;;^UTILITY(U,$J,358.4,942,0)
 ;;=INFECTIOUS DISEASE^35^73
 ;;^UTILITY(U,$J,358.4,943,0)
 ;;=LIVER DISEASE^36^73
 ;;^UTILITY(U,$J,358.4,944,0)
 ;;=MENTAL HEALTH^38^73
 ;;^UTILITY(U,$J,358.4,945,0)
 ;;=MOVEMENT DISORDERS^39^73
 ;;^UTILITY(U,$J,358.4,946,0)
 ;;=MUSCULOSKELETAL^40^73
 ;;^UTILITY(U,$J,358.4,947,0)
 ;;=NEUROLOGY^41^73
 ;;^UTILITY(U,$J,358.4,948,0)
 ;;=PAIN^42^73
 ;;^UTILITY(U,$J,358.4,949,0)
 ;;=PREVENTIVE HEALTH^43^73
 ;;^UTILITY(U,$J,358.4,950,0)
 ;;=PULMONARY^44^73
 ;;^UTILITY(U,$J,358.4,951,0)
 ;;=SEXUAL TRAUMA^45^73
 ;;^UTILITY(U,$J,358.4,952,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^46^73
 ;;^UTILITY(U,$J,358.4,953,0)
 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^73
 ;;^UTILITY(U,$J,358.4,954,0)
 ;;=SUBSTANCE DISORDERS^48^73
 ;;^UTILITY(U,$J,358.4,955,0)
 ;;=VARICOSE VEINS^50^73
 ;;^UTILITY(U,$J,358.4,956,0)
 ;;=WOMEN'S HEALTH^51^73
 ;;^UTILITY(U,$J,358.4,957,0)
 ;;=WOUNDS-INITIAL ENCOUNTER^52^73
 ;;^UTILITY(U,$J,358.4,958,0)
 ;;=COMA^20^73
 ;;^UTILITY(U,$J,358.4,959,0)
 ;;=CAUSES OF INJURY^19^73
 ;;^UTILITY(U,$J,358.4,960,0)
 ;;=DEMENTIA^21^73
 ;;^UTILITY(U,$J,358.4,961,0)
 ;;=LONG TERM CURRENT DRUG THERAPY^37^73
 ;;^UTILITY(U,$J,358.4,962,0)
 ;;=ACQUIRED ABSENCE OF BODY PART(S)^2^73
 ;;^UTILITY(U,$J,358.4,963,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^49^73
 ;;^UTILITY(U,$J,358.4,964,0)
 ;;=ACSC ACUTE KIDNEY FAILURE^3^73
 ;;^UTILITY(U,$J,358.4,965,0)
 ;;=ACSC ANGINA^4^73
 ;;^UTILITY(U,$J,358.4,966,0)
 ;;=ACSC ASTHMA/BRONCHITIS/COPD^5^73
 ;;^UTILITY(U,$J,358.4,967,0)
 ;;=ACSC CHF^6^73
 ;;^UTILITY(U,$J,358.4,968,0)
 ;;=ACSC DEHYDRATION^7^73
 ;;^UTILITY(U,$J,358.4,969,0)
 ;;=ACSC DIABETES TYPE 1^8^73
 ;;^UTILITY(U,$J,358.4,970,0)
 ;;=ACSC DIABETES TYPE 2^9^73
 ;;^UTILITY(U,$J,358.4,971,0)
 ;;=ACSC HYPERTENSION^10^73
 ;;^UTILITY(U,$J,358.4,972,0)
 ;;=ACSC INFECTIOUS GASTROENTERITIS^11^73
 ;;^UTILITY(U,$J,358.4,973,0)
 ;;=ACSC PNEUMONIA^12^73
 ;;^UTILITY(U,$J,358.4,974,0)
 ;;=ACSC UTI^13^73
 ;;^UTILITY(U,$J,358.4,975,0)
 ;;=ACSC VIRAL ENTERITIS^14^73
 ;;^UTILITY(U,$J,358.4,976,0)
 ;;=E-CIG/VAPE LUNG INJURY^23^73
 ;;^UTILITY(U,$J,358.4,977,0)
 ;;=NEW PATIENT^2^74
 ;;^UTILITY(U,$J,358.4,978,0)
 ;;=ESTABLISHED PATIENT^1^74
 ;;^UTILITY(U,$J,358.4,979,0)
 ;;=CONSULTATIONS^3^74
 ;;^UTILITY(U,$J,358.4,980,0)
 ;;=THERAPY MODALITIES/PROCEDURES^19^75
 ;;^UTILITY(U,$J,358.4,981,0)
 ;;=DRUGS/MEDICATION^6^75
